Vivos Therapeutics Inc. (VVOS)
NASDAQ: VVOS
· Real-Time Price · USD
4.07
-0.54 (-11.71%)
At close: Aug 15, 2025, 11:19 AM
Vivos Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.86M | -2.83M | -2.62M | -1.93M | -3.76M | -4.26M | -2.09M | -5.53M | -1.7M | -6.09M | -5.43M | -6.81M | -5.51M | -7.39M | -5.45M | -4.04M | -3.4M |
Depreciation & Amortization | 177K | 144K | 146K | 145K | 146K | 149K | 149K | 148K | 175K | 169K | 176K | 283K | 41K | 168.23K | 192.5K | 194.77K | 177.5K |
Stock-Based Compensation | 317K | 57K | 142K | 270K | 293K | 152K | 189K | 459K | 306K | 775K | 350K | 662K | 609K | 463.29K | 1.11M | 648.05K | 434.29K |
Other Working Capital | n/a | -365K | 1.77M | -1.22M | 772K | 264K | 1.21M | -275K | 13K | 1.09M | -497K | 211K | -333K | -1.46M | -416.5K | 1.46M | -87.53K |
Other Non-Cash Items | n/a | 5K | -2.62M | 26K | 561K | 112K | -1.76M | 6.99M | -2.55M | -124K | 244K | 405K | -1.04M | -7.48K | -9.7K | -5.87K | 14.05K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 192K | n/a | -5.94M | n/a | n/a | n/a | n/a | n/a | 911.28K | n/a | n/a | 231.72K |
Change in Working Capital | n/a | -319K | 757K | -1.56M | 802K | 906K | 713K | 1.01M | 233K | 2.27M | -1.18M | 794K | -174K | 1.74M | 99.79K | -488.08K | -1.32M |
Operating Cash Flow | -3.8M | -2.94M | -4.19M | -3.05M | -2.52M | -2.75M | -2.8M | -2.86M | -3.54M | -3M | -5.84M | -4.66M | -6.08M | -4.12M | -4.06M | -3.69M | -3.86M |
Capital Expenditures | n/a | -165K | 211K | -60K | -151K | -165K | -154K | -245K | -239K | -200K | -100K | -504K | -120K | -382.65K | -440.46K | -1.31M | -261.7K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -225K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -122K | -165K | -403K | n/a | -151K | -803K | n/a | n/a | -50K | n/a | n/a | n/a | -120K | 301.00 | 8.49K | -220.79K | -261.7K |
Investing Cash Flow | -122K | -165K | -192K | -60K | -151K | -165K | -154K | -245K | -289K | -200K | -100K | -504K | -120K | -382.35K | -431.97K | -1.53M | -261.7K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.5M | -1.5M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -446K | 3.79M | 7.4M | 3.63M | -432K | n/a | n/a | -645K | n/a | n/a | n/a | n/a | -434 | -500 | 25.37M | n/a |
Financial Cash Flow | n/a | 3.05M | 3.79M | 7.4M | 3.63M | 3.57M | n/a | n/a | 7.36M | n/a | n/a | n/a | n/a | -434 | -1.17M | 25.37M | -25K |
Net Cash Flow | -3.92M | -51K | -592K | 4.29M | 968K | 655K | -2.95M | -3.1M | 3.53M | -3.2M | -5.94M | -5.17M | -6.2M | -4.5M | -5.66M | 20.14M | -4.15M |
Free Cash Flow | -3.8M | -3.1M | -3.98M | -3.11M | -2.67M | -2.91M | -2.95M | -3.1M | -3.78M | -3.2M | -5.94M | -5.17M | -6.2M | -4.5M | -4.5M | -5M | -4.12M |